Search Results
Results found for "pain neuroscience"
- New Podcast, Sweet Structures & $2.2B GPCR Moves
Tune in for sharp insights, tenfold gains in efficacy, and the wisdom of knowing when to walk and when
- Overview of adhesion GPCRs self-activation
modulate protein-protein interactions; and also by the presence of the GPCR-Autoproteolysis INducing (GAIN endoplasmic reticulum, many of these receptors are cleaved at the GPCR Proteolysis Site motif of the GAIN When I started studying aGPCRs, the structural conformation of the GAIN domain of ADGRL1/Lphn1 and ADGRB3 These crystal structures showed how the Stalk region, which is a short peptide released from the GAIN during auto-proteolysis, has a β-lamin conformation and is held within the GAIN surrounded by numerous
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
In this lesson, you’ll gain: A strategic view of how chemical scaffolds shape pharmacologic outcomes Subscribers gain weekly lectures led by Dr.
- The Five Traps of Ignoring Kinetics
In this session, you'll gain: ✅ Tools to confirm true equilibrium and avoid potency errors from premature If you detect it, you gain texture that equilibrium constants alone can’t provide.
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
The main challenge was simple but daunting: “The challenge was to get a face to those proteins—the structure
- Understanding the Journey: Catherine Demery's Path to Addiction Science
After excelling in the PCAT and gaining admission to pharmacy school at the University of Michigan, it that environment, every project brought new challenges—deadlines, documentation, and deliverables for paying She gained exposure to in vivo models, immunology, and complex study design, while also getting closer
- ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
patients with severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), the two main
- Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge
It is well known that immune challenges, such as exposure to lipopolysaccharide, the main component of
- Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling
A hallmark of aGPCR activation is the removal of the inhibitory GAIN domain and the dipping of the cleaved
- Understanding Orthosteric Binding: The Key to Drug Action
You'll gain valuable insights into the critical role binding plays in pharmacology.
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Industry insights: Crinetics' Palsonify gains momentum in acromegaly, a key indicator for pipeline expansion Gain a competitive edge: Learn to leverage restricted diffusion and rebinding to create drugs with longer
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
Nanobodies have gained traction rapidly due to their biochemical tractability and their ability to recognize
- Chronic itch: emerging treatments following new research concepts
Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are the main
- Profiling Immune Cell and Platelet Transcriptomes
As the field continues to evolve, the insights gained from this research will be instrumental in shaping
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
Moreover, the main investigations into animal models and ongoing clinical trials using these unimolecular
- 📰 GPCR Weekly News, November 20 to 26, 2023
Tobias Langenhan for his papers to highlight suggestions GAIN Domain Unfolding in Adhesion GPCRs Molecular ADGRE2 to Circulating Neutrophils Is Not Related to Injury Severity Unveiling Mechanical Activation: GAIN
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
programs in key therapeutic areas Kallyope, pioneers in drug discovery involving the gut-brain axis, will gain
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
In this session, you’ll gain: ✅ A clear map of how drugs interact with enzymes before, during, and after Through stories, such as how ethanol competes with methanol in cases of poisoning, you can gain insight
- Accelerating GPCR Drug Discovery
If you're navigating a stuck GPCR program, planning your next crucial milestone, or struggling to gain
- Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling
also known to be capable of self-activation via an autoproteolysis process that removes the inhibitory GAIN
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
The mGlu5 receptor is activated by the main excitatory neurotransmitter of the nervous central system
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
perception, and thought, and have the activation of serotonin (5-HT) 2A receptors (5-HT2A Rs) as a main
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
The mGlu5 receptor is activated by the main excitatory neurotransmitter of the nervous central system
- G protein-coupled receptors that influence lifespan of human and animal models
substantial participation in a wide variety of processes of human pathophysiology and are one of the main
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain A.; Bazin, H.; Tinel, N.; Durroux, T.; Prézeau, L.; Trinquet, E.; Pin, J.-P.
- TLR4 biased small molecule modulators
Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
And when you chain your highest-paid scientists to repetitive admin work, you’re not solving problems That’s a chaos tax — and you’re paying it in cash, time, and morale.
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
We aimed to exploit other mamba venoms to enlarge the V2R-Kunitz peptide family and gain insight into
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
In This Session, You’ll Gain: ✅ Modeling tools to understand how restricted diffusion in tissues like
- How GPCR Spatial Signaling Sparked a Scientific Journey
Pay attention to that. What began as a quiet obsession soon demanded a bigger stage. control localised signaling, how disease hijacks these systems, and how to target them for therapeutic gain













